Boehringer Ingelheim Limited

Ellesfield Avenue, Bracknell, Berkshire, RG12 8YS
Telephone: +44 (0)1344 424 600
Fax: +44 (0)1344 741 298
WWW: http://www.boehringer-ingelheim.co.uk
Medical Information Direct Line: +44 (0)1344 741 286
Medical Information e-mail: medinfo@bra.boehringer-ingelheim.com

Patient Information Leaflet last updated on the eMC: 24/05/2010
PIL Motens 2mg and 4mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 24/05/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to drug interactions
Updated on 29/07/2009 and displayed until 24/05/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change of manufacturer
  • Change to side-effects
Updated on 18/09/2008 and displayed until 29/07/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 16/05/2007 and displayed until 18/09/2008
Reasons for adding or updating:
  • Change to date of revision
Updated on 09/05/2006 and displayed until 16/05/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 18/02/2003 and displayed until 09/05/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 05/01/2001 and displayed until 18/02/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   lacidipine